Clinical trials
Treatment clinical trials
Below are recruiting treatment clinical trials, each written for real people, not researchers. We’re tracking 8,580 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07029958RecruitingPhase 4
Transplant protocol for EBV-related T/NK lymphoproliferative disease
This trial tests a stronger transplant conditioning regimen to treat a rare immune disorder caused by the Epstein-Barr virus. It aims to improve outcomes and reduce a complication called graft-versus-host disease, where donor cells attack the patient's body.
BeijingAges birth–18 years - NCT07253688RecruitingPhase 3
Rifampin for staph infections on artificial heart valves
This trial tests adding the antibiotic rifampin to standard treatment for staph infections on prosthetic heart valves. It aims to see if this combination improves outcomes.
Montreal, QuebecAges 18 years+ - NCT07029841Recruiting
Catheter therapy study for acute pulmonary embolism patients
This study follows patients in Hong Kong who are treated with catheter-based therapy for acute pulmonary embolism. It aims to understand how well this treatment works.
Hong Kong, Hong KongAges 18 years+ - NCT07027709Recruiting
Hybrid ceramic veneers for better smiles
This trial tests how well hybrid ceramic laminate veneers work for fixing front teeth. It may help if you need cosmetic improvement and your teeth are healthy enough.
CairoAges 21 years+ - NCT06741085RecruitingPhase 2
Radiosurgery plus standard care for lung cancer spread to brain
This trial tests if adding stereotactic radiosurgery (focused radiation) to standard drug therapy is safe and effective for people with EGFR-mutant non-small cell lung cancer that has spread to the brain. It aims to improve control of brain metastases while continuing targeted therapy.
Miami, FloridaAges 18 years+ - NCT07019454Recruiting
Custom stent graft for aneurysms near the kidneys
This study tests a doctor-modified stent graft to treat a type of abdominal aortic aneurysm (just above the kidneys). It may be an option if your aneurysm is large, growing, or causing symptoms, and standard devices aren't suitable.
Springfield, MassachusettsAges 18 years+ - NCT05905926Enrolling by invitationPhase 3
Tenapanor safety study for teens with constipation-predominant IBS
This trial checks the safety of tenapanor in children and teens (ages 6 to under 18) with IBS-C. It is only for people who finished a previous related study and agreed to continue follow-up.
Foley, AlabamaAges 6–18 - NCT06587425RecruitingPhase 2
Combination therapy for CLDN18.2-positive advanced stomach cancer
This study tests a combination of three drugs (LM-302, Candonilimab, and Capecitabine) as the first treatment for advanced stomach cancer that has a specific protein (Claudin 18.2). It aims to see if the combination shrinks tumors and is safe.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT06588998RecruitingPhase 2
Gum graft vs. special membrane for implant gum recession
This study tests whether a special membrane made from animal tissue (xenogenic cortical membrane) works as well as a gum graft (connective tissue graft) to fix gum recession around dental implants. If you have thin gums and an implant with receding gum, this trial may help cover the exposed implant surface.
Tanta, Gharbia GovernorateAges 20–50 - NCT07011186RecruitingPhase 1/Phase 2
TQB3909 and azacitidine for myeloid cancers
This trial tests a new oral drug, TQB3909, combined with a standard chemotherapy drug (azacitidine) for people with acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS). The goal is to see if this combination is safe and effective.
Bengbu, AnhuiAges 18 years+ - NCT06723639Recruiting
Restoring the torn Achilles tendon
This trial is testing a new way to repair a completely torn Achilles tendon. It uses MRI scans to make sure the repair is as good as possible, aiming for better healing and recovery.
Copenhagen, CapitalAges 18–67 - NCT07072351RecruitingPhase 1/Phase 2
Radiation plus chemoimmunotherapy for gastroesophageal junction cancer
This trial tests a shorter course of radiation combined with chemotherapy and immunotherapy to shrink gastroesophageal junction cancer before surgery. It aims to make the tumor removable and improve outcomes.
Xiamen, FujianAges 18 years+ - NCT07747350Recruiting
Laser vs pain pills for braces pain in Malay women
This study compares a low-level laser treatment with standard painkillers to see which works better for reducing pain from getting braces. It is for Malay women aged 18-33 who have never had braces and are generally healthy.
Kota Bharu, KOTA BHARUAges 18–33 - NCT06441032Enrolling by invitation
Metal crown survival study
This study looks back at patient records to see how long single-tooth crowns and partial crowns made of precious metal or non-precious metal last. It aims to find out which type of metal may hold up better over time.
Göttingen, Lower SaxonyAges Any age - NCT07010237RecruitingPhase 2
Lower-dose immune therapy plus hetrombopag for older adults with severe aplastic anemia
This trial tests a milder version of immunosuppressive therapy combined with hetrombopag (a drug that helps bone marrow make blood cells) in people aged 65 years and older with severe aplastic anemia. The goal is to see if this approach is both safer and effective for older patients.
Tianjin, Tianjin MunicipalityAges 65 years+ - NCT07510581Enrolling by invitation
Microcurrent and cold therapy device for skin aging
This study tests a device that uses microcurrent and cold therapy to improve fine lines, wrinkles, firmness, brightness, and even skin tone. It may be a good option if you have sensitive skin and are looking for a non-invasive treatment.
Teaneck, New JerseyAges 25–65 - NCT06730386RecruitingPhase 1
Trial of AK138D1 for advanced solid tumors
This trial tests a new drug called AK138D1 for people with advanced solid tumors that have not responded to or can't tolerate standard treatments. The goal is to see if it is safe and effective.
Blacktown, New South WalesAges 18–75 - NCT07264127Recruiting
I-arch system for early orthodontic treatment
This study tests a new orthodontic tool, the I-arch system, for straightening the lower front teeth when they are moderately crowded. It aims to see how well the I-arch works during the first stage of braces treatment.
KarbalaAges 12 years+ - NCT06764355RecruitingPhase 2
Chemo, Immunotherapy, and Chemoradiation Before Surgery for Advanced Esophageal Cancer
This trial tests a combination of chemotherapy, immunotherapy, and chemoradiation before surgery for people with advanced esophageal squamous cell carcinoma. The goal is to see if this approach helps shrink the tumor and improve outcomes.
TaipeiAges 18–75 - NCT07006532Recruiting
Tocilizumab for chronic active antibody-mediated rejection
This trial tests whether the drug tocilizumab can help treat chronic active antibody-mediated rejection after a kidney transplant. It is for people whose kidney function is still fairly good and who have certain findings on biopsy.
TehranAges 18 years+ - NCT06593379Recruiting
Mobile app study for veterans with suicidal thoughts
This study tests a mobile app designed to help veterans who are having suicidal thoughts but don't have an immediate plan to hurt themselves. The goal is to see if the app can reduce these thoughts and provide support between therapy sessions.
Durham, North CarolinaAges 18 years+ - NCT05813418Recruiting
Finding blood and other clues for immune side effects
This study looks for early “predictive clues” (often blood or test markers) that can forecast immune-related side effects in people treated with immune checkpoint medicines. The goal is to help doctors recognize who may be more likely to have these side effects while receiving treatment.
Amiens, PicardieAges 18 years+ - NCT06594250Recruiting
Nasal staph bacteria in patients with staph bloodstream infection
This trial studies the bacteria living in the nose of patients with a staph bloodstream infection. It aims to better understand why some infections persist, which could lead to better treatments.
Saint-EtienneAges 18 years+ - NCT06868511RecruitingPhase 3
Minimally invasive clot removal with tenecteplase for deep brain bleed
This trial tests a minimally invasive procedure to remove deep brain bleeds using a special puncture guided by brain imaging, combined with a clot-dissolving drug called tenecteplase. It may help reduce damage from the bleed and improve recovery.
Beijing, ChinaAges 18–80
Hear when a new Treatment trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for treatment?
- Yes. Clin2 currently lists 8,580 recruiting treatment studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a treatment trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a treatment trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.